Ketamine Treatment for Mood Disorders


Join us for this seminar presented by Rachel Dalthorp, MD.

This presentation will provide an overview of the pharmacologic treatment of depression and shortfalls.  Ketamine, an NMDA receptor antagonist, will be described in detail including the mechanism of action, FDA approved uses and off label indications.  The infusion process will be described, along with expected future applications including the use of an adjunct for psychotherapy and the treatment of addiction, pain and other psychiatric disorders.

Call 918-438-4257 to RSVP today!

No comments yet.

Leave a Reply